MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjopen-2024-091176

Медицинская библиотека · BMJ open · 2024

Comparative effectiveness trial of metformin versus insulin for the treatment of gestational diabetes in the USA: clinical trial protocol for the multicentre DECIDE study.

Venkatesh Kartik K, MacPherson Cora, Clifton Rebecca G, Powe Camille E, Bartholomew Anna, Gregory Donna, Trinh Anne, McAlearney Ann Scheck, Fiechtner Lauren G, Catalano Patrick, Rice Donna, Cross Sharon, Kutay Huban, Gabbe Steven, Grobman William A, Costantine Maged M, Battarbee Ashley N, Boggess Kim, Katukuri Vivek, Eichelberger Kacey, Esakoff Tania, Feghali Maisa N, Harper Lori, Kaimal Anjali, Kole-White Martha, Mendez-Figueroa Hector, Mlynarczyk Malgorzata, Sciscione Anthony, Shook Lydia, Sobhani Nasim C, Stamilio David M, Werner Erika, Wiegand Samantha, Zera Chloe A, Zork Noelia M, Saade George, Landon Mark B

Протокол клинического исследованияСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

INTRODUCTION

Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. Glycaemic control decreases the risk of adverse pregnancy outcomes for the affected pregnant individual and the infant exposed in utero. One in four individuals with GDM will require pharmacotherapy to achieve glycaemic control. Injectable insulin has been the mainstay of pharmacotherapy. Oral metformin is an alternative option increasingly used in clinical practice. Both insulin and metformin reduce the risk of adverse pregnancy outcomes, but comparative effectiveness data from a well-characterised, adequately powered study of a diverse US population remain lacking. Because metformin crosses the placenta, long-term safety data, in particular, the risk of childhood obesity, from exposed children are also needed. In addition, the patient-reported experiences of individuals with GDM requiring pharmacotherapy remain to be characterised, including barriers to and facilitators of metformin versus insulin use.

METHODS AND ANALYSIS: In a two-arm open-label, pragmatic comparative effectiveness randomised controlled trial, we will determine if metformin is not inferior to insulin in reducing adverse pregnancy outcomes, is comparably safe for exposed individuals and children, and if patient-reported factors, including facilitators of and barriers to use, differ between metformin and insulin. We plan to recruit 1572 pregnant individuals with GDM who need pharmacotherapy at 20 US sites using consistent diagnostic and treatment criteria for oral metformin versus injectable insulin and follow them and their children through delivery to 2 years post partum. More information is available at www.decidestudy.org.

ETHICS AND DISSEMINATION: The Institutional Review Board at The Ohio State University approved this study (IRB: 2024H0193; date: 7 December 2024). We plan to submit manuscripts describing the results of each study aim, including the pregnancy outcomes, the 2-year follow-up outcomes, and mixed-methods assessment of patient experiences for publication in peer-reviewed journals and presentations at international scientific meetings.

TRIAL REGISTRATION NUMBER: NCT06445946.

Для цитирования: Venkatesh Kartik K, MacPherson Cora, Clifton Rebecca G, Powe Camille E, Bartholomew Anna, Gregory Donna, Trinh Anne, McAlearney Ann Scheck, Fiechtner Lauren G, Catalano Patrick, Rice Donna, Cross Sharon, Kutay Huban, Gabbe Steven, Grobman William A, Costantine Maged M, Battarbee Ashley N, Boggess Kim, Katukuri Vivek, Eichelberger Kacey, Esakoff Tania, Feghali Maisa N, Harper Lori, Kaimal Anjali, Kole-White Martha, Mendez-Figueroa Hector, Mlynarczyk Malgorzata, Sciscione Anthony, Shook Lydia, Sobhani Nasim C, Stamilio David M, Werner Erika, Wiegand Samantha, Zera Chloe A, Zork Noelia M, Saade George, Landon Mark B. Comparative effectiveness trial of metformin versus insulin for the treatment of gestational diabetes in the USA: clinical trial protocol for the multicentre DECIDE study.. BMJ open. 2024. DOI: 10.1136/bmjopen-2024-091176.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.